Johns Hopkins startup gets funding from company turning research into businesses - Technical.ly Baltimore

Business

May 15, 2018 12:45 pm

Johns Hopkins startup gets funding from company turning research into businesses

The first JHU company to receive funding from IP Group is Lorem Therapeutics, a startup looking to develop new cancer treatments.
Inside Johns Hopkins’ FastForward 1812.

Inside Johns Hopkins' FastForward 1812.

(Photo by Stephen Babcock)

A company that works to turn intellectual property into businesses is backing a new Johns Hopkins startup developing therapeutics to treat cancer.

IP Groupwhich works with a group of universities and government labs including Hopkins, is providing funding to Lorem Therapeutics. The company is led by Barbara Slusher, a Johns Hopkins School of Medicine professor who directs the university’s largest drug discovery program. It’s the first company to receive funding from the company, though the amount was not disclosed.

Lorem Therapeutics is focusing on development early stage therapeutics in the phase between initial drug discovery and when a treatment begins review by the FDA for status as an Investigational New Drug. The company will use the funding “to accelerate and enhance our drug discovery efforts around critical cancer indications,” Slusher said in a statement.

IP Group has a partnership with Johns Hopkins to identify scientific research at the university that could be turned into businesses. Through the partnership, IP Group provides expertise on building a business and scientific insight, along with capital.

IP Group is committed to supporting scientific discovery and is thrilled to work with Dr. Slusher,” IP Group CEO Michael Burychka said in a statement. “We look forward to building upon our relationship with Johns Hopkins and continuing to invest in novel science being developed at the university.”

Lorem Therapeutics is also receiving support from FastForward, Johns Hopkins Tech Ventures’ incubator program that provides space and resources for startups.

The partnership with IP Group is the second recent sign of the university working with an outside entity to identify commercially promising research. The university also established a joint venture with investment firm Deerfield Management that is looking to fund new startups developing therapeutics.

-30-
BECOME A CONTRIBUTOR TO THE JOURNALISM FUND TO COMMENT
Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

University of Maryland awarded $200M for flu vaccine research

Early Charm Ventures launches Abri Science with $225K in funding

Intelehealth launches crowdfunding campaign to expand primary care access around the world

SPONSORED

Baltimore

Why two eminent Baltimore higher-ed institutions collaborated to create this unique dual degree program

Annapolis Junction, MD

Asymmetrik

FULL-STACK DEVELOPER

Apply Now

Annapolis Junction, MD

Asymmetrik

SOFTWARE ENGINEER

Apply Now

Annapolis Junction, MD

Asymmetrik

FRONT-END DEVELOPER

Apply Now

Meet the Aerium: An algae air purifier created by IMET PhD candidates

AgeneBio receives $3.4M for development of Alzheimer’s treatment

5 questions with Jason Becker: Leading product development through an equity lens at Allovue

SPONSORED

Baltimore

What Asymmetrik is doing to help lead healthcare’s digital transformation

Baltimore

Protenus

DevOps Engineer

Apply Now

Philadelphia

Vistar Media

Sr. Software Engineer

Apply Now

Philadelphia

Vistar Media

Front End Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!